Member of the Association of American Physicians
His scientific interests lie mostly in Internal medicine, Immunology, Gastroenterology, Hepatitis and Hepatitis C. His research on Internal medicine frequently connects to adjacent areas such as Endocrinology. His work on Virology expands to the thematically related Immunology.
Jay H. Hoofnagle interconnects Liver cancer and Antibody in the investigation of issues within Virology. His studies in Gastroenterology integrate themes in fields like Liver transplantation, Surgery and Biopsy, Liver biopsy, Pathology. His Hepatitis C research includes elements of Alanine transaminase and Ribavirin.
Jay H. Hoofnagle spends much of his time researching Internal medicine, Immunology, Virology, Gastroenterology and Hepatitis. Internal medicine and Endocrinology are frequently intertwined in his study. His Immunology study is mostly concerned with Hepatitis B, Hepatitis C virus, Antibody, Hepatitis C and Alpha interferon.
His Hepatitis B research integrates issues from HBeAg and Hepatitis B virus. His study focuses on the intersection of Virology and fields such as Antigen with connections in the field of Immune system. His Gastroenterology research is multidisciplinary, incorporating perspectives in Chronic hepatitis, Surgery, Liver biopsy, Liver injury and Pathology.
Jay H. Hoofnagle focuses on Internal medicine, Gastroenterology, Liver injury, Immunology and Liver disease. His works in Prospective cohort study, Hepatology, Liver transplantation, Cirrhosis and Hepatitis C are all subjects of inquiry into Internal medicine. His work carried out in the field of Hepatitis C brings together such families of science as Ribavirin, Hepacivirus and Hepatitis C virus.
Jay H. Hoofnagle combines subjects such as Chronic hepatitis, Liver biopsy, Alkaline phosphatase and Hepatitis with his study of Gastroenterology. His Immunology study frequently links to adjacent areas such as Young adult. His study in Liver disease is interdisciplinary in nature, drawing from both Transient elastography, Nodular regenerative hyperplasia and Transplantation.
His primary areas of investigation include Internal medicine, Gastroenterology, Liver injury, Hepatology and Prospective cohort study. His Internal medicine research incorporates themes from Endocrinology and Immunology. His Hepatitis C, Ribavirin and Alpha interferon study in the realm of Immunology connects with subjects such as Context.
His Gastroenterology research is multidisciplinary, relying on both Biopsy, Liver biopsy, Hepatitis, Placebo and Alkaline phosphatase. His study looks at the intersection of Hepatitis and topics like Pathology with Hyperlipidemia and Statin. His Liver injury study integrates concerns from other disciplines, such as Chronic liver disease, Liver transplantation and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
F. Alvarez;P. A. Berg;F. B. Bianchi;L. Bianchi.
Journal of Hepatology (1999)
Classification of chronic hepatitis: diagnosis, grading and staging.
Valeer J. Desmet;Michael Gerber;Jay H. Hoofnagle;Michael Manns.
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Arun J. Sanyal;Naga Chalasani;Kris V. Kowdley;Arthur McCullough.
The New England Journal of Medicine (2010)
Viral Hepatitis and Liver Disease
Girish N. Vyas;Jules Dienstag;Jay H. Hoofnagle.
Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.
A. M. Di Bisceglie;P. Martin;C. Kassianides;M. Lisker-Melman.
The New England Journal of Medicine (1989)
THE TREATMENT OF CHRONIC VIRAL HEPATITIS
Hoofnagle Jh;di Bisceglie Am.
The New England Journal of Medicine (1997)
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.
Hoofnagle Jh;Mullen Kd;Jones Db;Rustgi.
The New England Journal of Medicine (1986)
Overweight, obesity, and health risk.
C. J. Billington;L. H. Epstein;N. J. Goodwin;J. O. Hill.
JAMA Internal Medicine (2000)
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
Jordan J. Feld;Jay H. Hoofnagle.
Pathogenesis, natural history, treatment, and prevention of hepatitis C.
Liang Tj;Rehermann B;Seeff Lb;Hoofnagle Jh.
Annals of Internal Medicine (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: